Celltrion
068270.KS
#722
Rank
ยฃ22.03 B
Marketcap
ยฃ100.97
Share price
1.84%
Change (1 day)
-3.03%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): ยฃ2.48

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ2.32. In 2022 the company made an earnings per share (EPS) of ยฃ2.26 a decrease over its 2021 EPS that were of ยฃ2.69.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ2.489.86%
2022ยฃ2.26-15.84%
2021ยฃ2.6912.77%
2020ยฃ2.3870.79%
2019ยฃ1.3915.63%
2018ยฃ1.21-33.13%
2017ยฃ1.80141.17%
2016ยฃ0.758.28%
2015ยฃ0.6911.28%
2014ยฃ0.6216.37%
2013ยฃ0.53-67.42%
2012ยฃ1.6484.22%
2011ยฃ0.8962.13%
2010ยฃ0.5580.61%
2009ยฃ0.30-559.63%
2008-ยฃ0.06604-123.16%
2007ยฃ0.29